Attention-Deficit/Hyperactivity Disorder (ADHD) Market Analysis, Leading Companies, Emerging Drugs and Epidemiology Forecast

July 31 20:30 2020
Attention-Deficit/Hyperactivity Disorder (ADHD) Market Analysis, Leading Companies, Emerging Drugs and Epidemiology Forecast

Delveinsight Business Research
DelveInsight’s “Attention-Deficit/Hyperactivity Disorder (ADHD) Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the Attention-Deficit/Hyperactivity Disorder (ADHD), historical and forecasted epidemiology as well as the Attention-Deficit/Hyperactivity Disorder (ADHD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Attention-deficit/hyperactivity disorder (ADHD) is a brain disorder marked by an ongoing pattern of inattention and/or hyperactivity-impulsivity that interferes with functioning or development. ADHD is a group of behaviors and is also called as attention deficit disorder (ADD). ADHD is a behavioral disorder that includes symptoms such as inattentiveness, hyperactivity, and impulsiveness.

Symptoms of ADHD tend to be noticed at an early age and may become more noticeable when a child’s circumstances change, such as when they start school. Most cases are diagnosed when children are 6 to 12 years old. The symptoms of ADHD usually improve with age, but many adults who were diagnosed with the condition at a young age continue to experience problems. People with ADHD may also have additional problems, such as sleep and anxiety disorders.

According to a study conducted by Guifeng et al. titled “Twenty-Year Trends in Diagnosed AttentionDeficit/Hyperactivity Disorder among US Children and Adolescents, 1997–2016,” published in 2018, estimated the prevalence of diagnosed attention-deficit/hyperactivity disorder increased significantly between 1997 and 2016. It has also been observed that the prevalence in children varied between 7.7% and 13.5%.

 

Get FREE sample copy at: 

https://www.delveinsight.com/sample-request/attention-deficit-hyperactivity-disorder-adhd-market

 

 attention-deficit-hyperactivity-disorder-adhd-market

 

The Attention-Deficit/Hyperactivity Disorder (ADHD) market report also covers emerging drugs, current treatment practices, Attention-Deficit/Hyperactivity Disorder (ADHD) market share of the individual therapies, current and forecasted Attention-Deficit/Hyperactivity Disorder (ADHD) Market Size from 2017 to 2030 segmented by seven major markets. The report provides a detailed current Attention-Deficit/Hyperactivity Disorder (ADHD) treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market. 

 

Attention-Deficit/Hyperactivity Disorder (ADHD) Market Key Facts

 As per DelveInsight’s assessment based on the recent studies and registries, estimated that the European 5 countries and US accounts for the 61% and 28% of the total prevalent cases out of all the ADHD cases in seven major markets in 2017.

Among the European countries, France had the highest diagnosed prevalent population of ADHD with 2,387,148 cases, followed by Italy in 2017.

As per the DelveInsight’s Analysis, it is observed that severe Attention Deficit Hyperactivity Disorder (ADHD) cases are found more in males than in females.

 

Key Benefits of Attention-Deficit/Hyperactivity Disorder (ADHD) Market Report

  • Attention-Deficit/Hyperactivity Disorder (ADHD) market report provides an in-depth analysis of Attention-Deficit/Hyperactivity Disorder (ADHD) Market Size, Share, Trend, Epidemiology and Market Forecast till 2030, in 7 major market i.e. EU5 (Germany, Italy, Spain, France and the UK), Japan, and the United States.

  • The Attention-Deficit/Hyperactivity Disorder (ADHD) market report will help in developing business strategies by understanding the Attention-Deficit/Hyperactivity Disorder (ADHD) Market trends & developments, key players and future market competition that will shape and drive the Attention-Deficit/Hyperactivity Disorder (ADHD) market in the upcoming years.

  • The Attention-Deficit/Hyperactivity Disorder (ADHD) market report covers Attention-Deficit/Hyperactivity Disorder (ADHD) current treatment practices, emerging drugs, market share of the individual therapies in 7 MM.

  • The report provides a detailed assessment of the Attention-Deficit/Hyperactivity Disorder (ADHD) market in terms of market drivers & barriers, Unmet Needs, market opportunities, patient population,  comparative analysis of pipeline products with detailed clinical profiles, and other factors. 

 

Attention-Deficit/Hyperactivity Disorder (ADHD) Market

The total market size of ADHD is calculated by including both the market size for children and adults. The Attention-deficit/hyperactivity disorder (ADHD) market is expected to show positive growth in the coming years. In 2017, the United States accounts for the largest market size of Attention Deficit Hyperactivity Disorder, in comparison to EU5 (the United Kingdom, Germany, Italy, France, and Spain) and Japan. 

Some of the key factors such as Robust Pipeline Activity, Increased public awareness are expected to drive the Attention-deficit/hyperactivity disorder (ADHD) market forward in the coming years.

The Attention-Deficit/Hyperactivity Disorder (ADHD) market outlook section of the report helps to build the detailed comprehension of the historic, current and forecasted Attention-Deficit/Hyperactivity Disorder (ADHD) market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand for better technology. 

The report gives a thorough detail of Attention-Deficit/Hyperactivity Disorder (ADHD) market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders. 

 

Attention-Deficit/Hyperactivity Disorder (ADHD) Epidemiology

Attention Deficit Hyperactivity Disorder (ADHD) is a disorder marked by an ongoing pattern of inattention and/or hyperactivity-impulsivity that interferes with functioning or development. Inattention and hyperactivity/impulsivity are the key behaviors of ADHD. Some people with ADHD only have problems with one of the behaviors, while others have both inattention and hyperactivity-impulsivity. Most children have the combined type of ADHD.

 The Attention-Deficit/Hyperactivity Disorder (ADHD) epidemiology section covers insights about historical and current Attention-Deficit/Hyperactivity Disorder (ADHD) patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.

It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

 

Attention-Deficit/Hyperactivity Disorder (ADHD) Drugs Uptake and Key Market Players

The Attention-Deficit/Hyperactivity Disorder (ADHD) Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Attention-Deficit/Hyperactivity Disorder (ADHD) market or expected to get launched in the market during the study period. The analysis covers Attention-Deficit/Hyperactivity Disorder (ADHD) market uptake by drugs; patient uptake by therapies; and sales of each drug.    

Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

Some of the leading Companies worldwide, are coming up with novel therapeutic approaches that can entirely change the treatment landscape of Attention Deficit Hyperactivity Disorder (ADHD) in the coming years.

Key pharma players in the Attention-deficit/hyperactivity disorder (ADHD) market.
KemPharm
Supernus Pharmaceuticals
Sumitomo Dainippon Pharma
Otsuka Pharmaceuticals
AEVI Genomic Medicine
Amarantus Bioscience
NLS Pharma
RespireRx Pharmaceuticals
And many more

Drugs Covered
Dasotraline
SPN-812
centanafadine
KP415
KP484
AEVI-001
Eltoprazine
NLS-1 mazindol CR
CX717
And many more

 

Table of Content

1. Key Insights

2. Executive Summary 

3. Attention-Deficit/Hyperactivity Disorder (ADHD) Competitive Intelligence Analysis

4. Attention-Deficit/Hyperactivity Disorder (ADHD) Market Overview at a Glance

5. Attention-Deficit/Hyperactivity Disorder (ADHD) Disease Background and Overview

6. Attention-Deficit/Hyperactivity Disorder (ADHD) Patient Journey

7. Attention-Deficit/Hyperactivity Disorder (ADHD) Epidemiology and Patient Population

8. Attention-Deficit/Hyperactivity Disorder (ADHD) Treatment Algorithm, Current Treatment, and Medical Practices

9. Attention-Deficit/Hyperactivity Disorder (ADHD) Unmet Needs

10. Key Endpoints of Attention-Deficit/Hyperactivity Disorder (ADHD) Treatment

11. Attention-Deficit/Hyperactivity Disorder (ADHD) Marketed Products

12. Attention-Deficit/Hyperactivity Disorder (ADHD) Emerging Therapies

13. Attention-Deficit/Hyperactivity Disorder (ADHD) Seven Major Market Analysis

14. Attribute Analysis

15. Attention-Deficit/Hyperactivity Disorder (ADHD) Market Outlook (7 major markets)

16. Attention-Deficit/Hyperactivity Disorder (ADHD) Access and Reimbursement Overview

17. KOL Views on the Attention-Deficit/Hyperactivity Disorder (ADHD) Market.

18. Attention-Deficit/Hyperactivity Disorder (ADHD) Market Drivers

19. Attention-Deficit/Hyperactivity Disorder (ADHD) Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

 

Related Reports

 Attention-deficit/hyperactivity disorder (ADHD) Epidemiology Forecast to 2030

DelveInsight’s Attention-deficit/hyperactivity disorder (ADHD) Epidemiology Forecast 2030 report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology of Attention-deficit/hyperactivity disorder (ADHD) in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

 

Attention-deficit/hyperactivity disorder (ADHD) Pipeline Insights, 2020

Attention-deficit/hyperactivity disorder (ADHD) Pipeline Insight, 2020 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Attention-deficit/hyperactivity disorder (ADHD) market.

 

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Anuj Rawat
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/

view more articles

About Article Author